The State of Physician Practice M&A: What Sellers Need to Know in 2026
If you’re a physician who has been thinking about selling your practice, the market you’re entering in 2026 looks meaningfully different from the one that existed five years ago. It’s more sophisticated, more competitive in some specialties, more cautious in others, and more consequential for the physicians navigating it without the right guidance.
This post is designed to give you a ground-level view of where the market stands today: who’s buying, what they’re paying, where valuations have settled after several years of volatility, and what the most important questions are for physician sellers to be asking right now.
The Consolidation Wave Is Mature — But It Hasn’t Crested
Physician practice consolidation has been underway for well over a decade, driven primarily by private equity firms, health systems, and increasingly by hybrid models that blend elements of both. What’s changed is that this is no longer a nascent trend. It’s a mature market, and that maturity cuts both ways.
On the positive side, buyers are more experienced, deal structures are more standardized, and physicians entering a transaction today have more precedent to draw on than their counterparts did ten years ago. The mechanics of these deals are better understood, even if they remain complex.
On the challenging side, buyer selectivity has increased. The era of aggressive platform-building — when PE-backed groups were acquiring nearly any practice that showed reasonable financials — has given way to a more disciplined approach. Buyers are more focused on EBITDA thresholds, geographic fit, payor mix quality, and a practice’s ability to grow within a larger platform. Practices that don’t meet those criteria are finding the buyer universe thinner than they might have expected.
The takeaway for sellers: the market remains active and, in the right specialties, quite favorable. But assuming that interest will be abundant simply because consolidation is ongoing is a mistake. How you position your practice — and who represents you in that positioning — matters more than it did when buyers were competing aggressively for nearly every available asset.
Where Private Equity Stands Today
Private equity remains the most consequential force in physician practice M&A, and understanding how PE firms are operating right now is essential context for any potential seller.
The past few years brought a period of recalibration. Rising interest rates increased the cost of the leveraged debt that PE-backed platforms rely on to finance acquisitions, which put real pressure on deal economics and caused some platforms to slow their acquisition pace. That pressure hasn’t fully resolved, but the market has adapted. Sponsors have become more creative with deal financing, and the most well-capitalized platforms have continued acquiring — just more selectively.
What hasn’t changed is the fundamental PE investment thesis: acquire physician practices, consolidate them into a larger platform, improve operational efficiency, and exit at a higher multiple than the entry price — typically through a sale to a larger PE firm or a strategic acquirer. Understanding that thesis matters because it tells you what buyers are actually looking for. They want practices that are operationally clean, financially transparent, growing or stable, and capable of functioning within a larger organizational structure. They are buying a business, and they are evaluating yours as one.
The specialties attracting the most sustained PE interest in 2026 include dermatology, gastroenterology, ophthalmology and retina, orthopedics, pain management, and behavioral health — though activity extends well beyond this list into primary care, pediatrics, oncology, anesthesia, and a range of surgical subspecialties. If your specialty isn’t on that list, it doesn’t mean buyers aren’t interested. It means the conversation about value and fit requires more nuance.
Health Systems Are Back at the Table
After a period in which many health systems pulled back from physician employment — stung by operating losses and the operational complexity of managing large, employed physician networks — health systems have returned as serious acquirers in many markets.
The motivations are familiar: securing referral networks, expanding geographic reach, protecting market share against PE-backed competitors, and increasingly, addressing physician shortages in key service lines. What’s different now is that health systems are approaching acquisitions with greater financial discipline than in earlier waves of consolidation. They are more focused on the economics of physician employment and more likely to structure transactions with performance components rather than simply absorbing a practice at a fixed price.
For physicians, health system acquisition can offer real advantages — institutional resources, malpractice coverage, retirement benefits, and the removal of administrative burdens that have consumed increasing portions of physician time and energy. But it also typically means less autonomy, compensation structures tied to productivity metrics, and an employment relationship that can feel significantly different from practice ownership. Understanding the full picture — not just the headline purchase price — is critical before entering a conversation with any health system acquirer.
Valuation: Where Things Actually Stand
Valuations in physician practice M&A are almost always expressed as a multiple of EBITDA — earnings before interest, taxes, depreciation, and amortization — and those multiples have moderated from the peaks reached in 2020 and 2021, when cheap capital and aggressive platform-building drove some transactions to levels that, in retrospect, were difficult to justify.
Today’s multiples vary considerably by specialty, practice size, geography, and payor mix, but a general framework looks something like this: smaller practices in less competitive specialties may transact in the four to seven times EBITDA range, while larger, well-performing practices in high-demand specialties can still command eight to twelve times or higher in competitive processes. The difference between those outcomes is rarely about luck. It’s almost always about how the practice was prepared, how the transaction was structured, and how many qualified buyers were at the table.
One important note on EBITDA: the number your accountant has been using for tax purposes is almost never the number a buyer will use for valuation. Buyers perform their own analysis, identify add-backs and adjustments, and arrive at a normalized EBITDA that reflects the true earnings power of the business. Understanding how that normalization works — and having an advisor who can present it favorably and accurately — is one of the most concrete ways that representation pays for itself.
What’s Driving Physicians to Sell Right Now
The motivations bringing physicians to the transaction market in 2026 are as varied as the physicians themselves, but several themes come up consistently in our conversations.
Administrative burden continues to top the list. Prior authorizations, documentation requirements, payor negotiations, staffing challenges, and the operational complexity of running a business alongside a clinical practice have accumulated to a point where many physicians are simply exhausted. A transaction that transfers those burdens to a larger organization — while delivering meaningful liquidity — is an attractive proposition even for physicians who never imagined themselves as sellers.
Succession planning is the other dominant driver, particularly among physicians in their fifties and sixties who built practices over decades and now face a genuine question about what happens to those practices — and the patients in them — when they’re ready to step back. A well-structured transaction can answer that question while also rewarding the physician for what they’ve built.
Uncertainty about the reimbursement environment, particularly around Medicare rates and the ongoing pressures facing independent practices, is pushing more physicians toward a transaction sooner than they originally planned. The calculus of remaining independent has shifted, and for many physicians, the question is no longer whether to sell but when — and to whom.
What Smart Sellers Are Doing Differently
The physicians who achieve the best outcomes in this market share a few common traits, and none of them are accidental.
They start early. The preparation that produces a clean, well-presented practice for sale — normalized financials, organized contracts, a clear operational narrative — takes time. Physicians who begin that process twelve to twenty-four months before they want to close are consistently better positioned than those who decide to sell and expect to close within a few months.
They run a process. The single biggest driver of valuation in any transaction is competition among buyers. Physicians who engage with a single buyer — often the first one who called — routinely leave significant money on the table. A structured process that brings multiple qualified buyers to the table creates leverage that no amount of negotiation with a single buyer can replicate.
They get independent representation. The buyers in these transactions are sophisticated, well-advised, and have completed dozens or hundreds of deals. A physician seller entering that dynamic without an experienced advisor on their side is at a structural disadvantage from the first conversation. The cost of representation is almost always recovered many times over in the transaction outcome — and that’s before accounting for the terms that don’t show up in the headline purchase price but matter enormously after closing.
The Bottom Line for 2026
The market for physician practice transactions in 2026 is active, sophisticated, and consequential. Buyers are disciplined and selective. The gap between what an unprepared seller achieves and what a well-prepared seller achieves has never been wider. And the decisions made in the early stages of a transaction — about timing, preparation, buyer selection, and deal structure — have an outsized impact on the outcome.
If you’re considering a transaction, the right time to start the conversation isn’t when you’ve made up your mind. It’s before that — when you still have the time and flexibility to position your practice properly and make deliberate decisions rather than reactive ones.
We work exclusively with physician sellers, and that singular focus shapes everything about how we approach a transaction. If you’d like to understand what your practice might be worth in today’s market, or simply talk through whether a transaction makes sense for your situation, we’d welcome the conversation.
Alexander Price & Co.
Healthcare Transaction Advisory
info@alexanderpriceandco.com | www.alexanderpriceandco.com
The information contained in this post is intended for general informational purposes and does not constitute legal, tax, or financial advice. Physicians considering a practice transaction should consult with qualified legal and financial advisors in addition to an experienced transaction advisor.
